TP53 and colorectal carcinoma: Most sporadic CRCs lose APC function during adenoma development; then, mutations in other tumor suppressor genes or oncogenes, including TP53, KRAS, and SMAD4, lead to CRC initiation, promotion, and progression [141,142].